BRAF (V600E) associates with cytoplasmatic localization of p27kip1 and higher cytokeratin 19 expression in papillary thyroid carcinoma. - Wikidata - awgldk - TriplyDB

BRAF (V600E) associates with cytoplasmatic localization of p27kip1 and higher cytokeratin 19 expression in papillary thyroid carcinoma.

BRAF (V600E) associates with cytoplasmatic localization of p27kip1 and higher cytokeratin 19 expression in papillary thyroid carcinoma.

http://www.wikidata.org/entity/Q46475619

about

Nodular goiter with amyloid deposition in an elderly patient: fine-needle cytology diagnosis and review of the literature Early cytological diagnosis of extranodal stage I, primary thyroid Non-Hodgkin lymphoma in elderly patients. Report of two cases and review of the literature.Cytological diagnosis of thyroid nodules in Hashimoto thyroiditis in elderly patients Cytological diagnosis of adult-type fibrosarcoma of the neck in an elderly patient. Report of one case and review of the literature Genetic mutations in the treatment of anaplastic thyroid cancer: a systematic review.Diagnostic utility of BRAFV600E mutation testing in thyroid nodules in elderly patients.Galectin-3 Performance in Histologic a Cytologic Assessment of Thyroid Nodules: A Systematic Review and Meta-Analysis.Ras oncoprotein disrupts the TSH/CREB signaling upstream adenylyl cyclase in human thyroid cell.BRAF(V600E) assessment by pyrosequencing in fine needle aspirates of thyroid nodules with concurrent Hashimoto's thyroiditis is a reliable assay.Midkine expression is associated with clinicopathological features and BRAF mutation in papillary thyroid cancer.BRAF mutation positive papillary thyroid carcinoma is less advanced when Hashimoto's thyroiditis lymphocytic infiltration is present.Prognostic significance of cytokeratin 19 expression in pancreatic neuroendocrine tumor: A meta-analysis.Correlation between polymorphisms of BRAF gene and papillary thyroid carcinoma.

P2860

Q27025120-41C802BF-E14D-4C1D-843F-5434C4E2A91E Q27690371-9F8E3E4E-F200-4801-B564-0E7FF5361C03 Q35050925-DF5083E7-DA47-49F5-A1C8-C38478CF98BE Q35050977-A03C9333-6B02-4B39-A903-056B4B1B3DCA Q35051065-62D10B91-2B18-49E2-8499-BA4ACAA30E6C Q35051461-5111DB42-C46C-4346-A8A9-C70AD646C023 Q38628967-B07C77EB-ECBA-42F8-B632-3A6773F22C5C Q38995868-A81CDAE9-0109-4FB8-A5CE-76F64C29DD54 Q43429193-925C6F23-EBB4-45A1-8229-5053B913A1AA Q44425656-69D409D4-CC13-45A0-AC2B-BEF672D7E803 Q46527691-F7105987-E0C6-44E2-843B-642B438F802E Q47108788-8037D947-8675-4EE0-87C9-70D1A47280F6 Q54164764-E307A5D5-3200-4DC8-B965-C7A423CFAAA7

P2860

BRAF (V600E) associates with cytoplasmatic localization of p27kip1 and higher cytokeratin 19 expression in papillary thyroid carcinoma.

http://www.wikidata.org/entity/Q46475619

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年学术文章

@wuu

2012年学术文章

@zh

2012年学术文章

@zh-cn

2012年学术文章

@zh-hans

2012年学术文章

@zh-my

2012年学术文章

@zh-sg

2012年學術文章

@yue

2012年學術文章

@zh-hant

name

BRAF (V600E) associates with c ...... n papillary thyroid carcinoma.

@en

type

label

BRAF (V600E) associates with c ...... n papillary thyroid carcinoma.

@en

prefLabel

BRAF (V600E) associates with c ...... n papillary thyroid carcinoma.

@en

P1433

Q46475619-EF61C503-1D5C-428B-BC99-4193202DE9F9

P1476

Q46475619-D88F2C69-BD9B-4830-91FF-AFCB806E1354

P2093

Q46475619-31DBA2E7-E23C-4119-B09A-FB871ACEAAD7

Q46475619-8D7116CE-3CA9-4BC6-A52D-8767CAEE08D3

Q46475619-8EA0AFE0-2C8F-41AC-9705-01B85A2AECBE

Q46475619-9E6F80F4-11EB-4441-9E07-01839F6C16BF

Q46475619-A144FD9F-75B7-4074-8DE1-2B42E43C48EB

Q46475619-A16DD1C0-43EA-4A31-9FD0-38EC784D70A7

Q46475619-AD46ED2F-0A2E-4E3F-9E8A-D4B969D96F77

Q46475619-B2AE8F2A-FB15-4033-AE3F-140665C55749

P2860

Q46475619-0423A855-9D32-4035-89CF-AE8AE99120C3

Q46475619-090442A8-C1C8-4619-896C-74E5CF259210

Q46475619-325B60E8-76AD-48A9-BE25-F763F30789FC

Q46475619-396E5AF3-A6DB-4861-9F12-D469A67989F3

Q46475619-3BCFDAB4-FFCC-4D42-8EB5-0D3680330152

Q46475619-3FA63ADF-D99B-4E65-909F-0CA7EA6FBC43

Q46475619-454C8E76-ACB3-4B8E-A996-9AA2A0A7C544

Q46475619-4B048886-025E-4D97-AA5A-322C14886865

Q46475619-57CF3640-80BE-458F-99CC-D4B7A03ADF03

Q46475619-5D74A1B4-9896-4D61-94F6-799C003E7B3E

P2888

Q46475619-B270C825-FB9C-4CF5-84FB-71B390A25A51

P304

Q46475619-03345717-6424-4CEB-8A4A-17CFAA62591B

P31

Q46475619-F39A3F98-4130-47C7-AE45-90E90B784BAB

P356

Q46475619-765DE3A2-1019-470A-9BDE-564CFB40E312

P433

Q46475619-E50897A2-D5BA-4183-A14E-7F26852E5A38

P478

Q46475619-071236BC-7BB6-4972-BEA8-453F14AC8C16

P50

Q46475619-865DBD08-CDE2-4400-A7A0-2BB68D41DC54

Q46475619-894755EB-2767-4252-92BC-07F4486EC485

P577

Q46475619-896B415B-1EE6-4DCA-81EC-9F03CE321DF5

P5875

Q46475619-D4A9742E-49BA-49B2-A969-C3BC2D62EE86

P698

Q46475619-07EF2020-94BE-4B75-B40E-449B98258921

P356

S12020-012-9843-4

P1433

P1476

BRAF (V600E) associates with c ...... in papillary thyroid carcinoma

@en

P2093

Alessia Caleo

http://www.w3.org/2001/XMLSchema#string

Anna Guerra

http://www.w3.org/2001/XMLSchema#string

Manuela Motta

http://www.w3.org/2001/XMLSchema#string

Mario Vitale

http://www.w3.org/2001/XMLSchema#string

Maurilio Deandrea

http://www.w3.org/2001/XMLSchema#string

Paolo Piero Limone

http://www.w3.org/2001/XMLSchema#string

Pio Zeppa

http://www.w3.org/2001/XMLSchema#string

Silvano Esposito

http://www.w3.org/2001/XMLSchema#string

P2860

Role of the ubiquitin-proteasome pathway in regulating abundance of the cyclin-dependent kinase inhibitor p27

Quantitative and qualitative differences in protein expression between papillary thyroid carcinoma and normal thyroid tissue.

Phosphorylation-dependent degradation of the cyclin-dependent kinase inhibitor p27

The primary occurrence of BRAF(V600E) is a rare clonal event in papillary thyroid carcinoma.

Decreased levels of the cell-cycle inhibitor p27Kip1 protein: prognostic implications in primary breast cancer.

Increased proteasome-dependent degradation of the cyclin-dependent kinase inhibitor p27 in aggressive colorectal carcinomas.

BRAF mutation predicts a poorer clinical prognosis for papillary thyroid cancer.

Identification of galectin-3 as a factor in pre-mRNA splicing.

Complex regulation of the cyclin-dependent kinase inhibitor p27kip1 in thyroid cancer cells by the PI3K/AKT pathway: regulation of p27kip1 expression and localization

Nucleocytoplasmic lectins.

P2888

s12020-012-9843-4

P304

165-171

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S12020-012-9843-4

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

44

http://www.w3.org/2001/XMLSchema#string

P50

Franco Fulciniti

Vincenzo Marotta

P577

2012-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

233829306

http://www.w3.org/2001/XMLSchema#string

P698

23203004

http://www.w3.org/2001/XMLSchema#string